Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Vital Access

Explore full profile

Improving Fistula Access For Dialysis Patients

Salt Lake City, United StatesFounded 2008Biotech & Life Sciences
Valuation $5–10M Last recorded · 2012
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Vital Access and the history behind them.

About Vital Access

Vital Access Corp. was a development-stage medical device company established in 2006 and headquartered in Salt Lake City, Utah. The company, formerly operating under the name IVIT, was founded by Dr. Duane Blatter, who also served as its Chief Medical Officer. The firm focused on creating surgical and interventional technologies to enhance vascular access for patients undergoing hemodialysis for kidney failure.

The company's principal product was the VWING™ Vascular Needle Guide, a patented, surgically implanted titanium device. It was designed to provide a consistent and easily palpable target for needle insertion into arteriovenous fistulas (AVF), which are often difficult to access, especially in obese patients. The VWING guide is placed subcutaneously and attached to the fistula wall, facilitating repeated, reliable access through a single puncture site using a 'buttonhole' cannulation technique. This approach was shown to reduce complications and improve the long-term durability of the fistula. The device received FDA 510(k) clearance in 2013, supported by clinical evidence from the multi-center SAVE study, which demonstrated its safety and effectiveness in converting previously unusable fistulas into reliable access points.

Vital Access Corp. operated in the surgical devices market, catering to vascular surgeons and nephrologists treating patients with end-stage renal disease. Its business model centered on the development and commercialization of its proprietary vascular access technologies. The company successfully raised capital to fund its operations and global expansion efforts, securing a significant $10 million credit facility from healthcare investment firm Deerfield Management in 2015, with Orchestra Medical Ventures as its lead equity investor. In a strategic move to broaden its product portfolio and gain entry into the U.S. market, Singapore-based Advent Access acquired the global manufacturing and commercialization rights for the VWING product line and other key assets from Vital Access on October 4, 2018.

Source: Dealroom company data

At a glance

Founded
2008
Headquarters
Salt Lake City, United States
Sector
Biotech & Life Sciences

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • Deerfield
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Salt Lake City HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Vital Access on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Vital Access on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.